Should you get the J&J vaccine? Why Dr. Atul Gawande says yes
On Thursday, February 4, Johnson & Johnson requested emergency FDA approval for its single-shot vaccine. In the days since the company first released efficacy and safety data, many of the headlines focused on its lower efficacy rate compared to that of mRNA vaccines from Pfizer and Moderna. But that's the wrong takeaway, says surgeon, public health expert and former member of Biden-Harris Transition COVID-19 Advisory Board, Dr. Atul Gawande. "This is a highly effective vaccine. It stops people from getting sick. If some people have some sniffles and mild effects from the coronavirus, that's okay, this is going to stop the deadly disease. And that is the ultimate goal of the vaccine."
Gawande's conversation with Ian Bremmer is part of the latest episode of GZERO World, whichstarts airing on public television nationwide beginning this Friday, February 5th. Check local listings.